US Bancorp
AURA icon

US Bancorp’s Aura Biosciences AURA Stock Holding History

US Bancorp’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$535 Sell
80
-138
-63% -$792 ﹤0.01% 3997
2025
Q4 		$1.19K Hold
218
– – ﹤0.01% 3833
2025
Q3 		$1.35K Hold
218
– – ﹤0.01% 3796
2025
Q2 		$1.36K Buy
+218
New +$1.27K ﹤0.01% 3919
2025
Q1 		– Sell
-27
Closed -$222 – 4196
2024
Q4 		$222 Buy
+27
New +$254 ﹤0.01% 4073

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

US Bancorp's AURA Position: Q1 2026 in Review

US Bancorp reduced its Aura Biosciences (AURA) stake by 63% in Q1 2026, selling an estimated $792 and leaving 80 shares worth $535. The position accounts for ﹤0.01% of the portfolio, ranked #3997.

US Bancorp first reported a position in AURA in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.36K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • US Bancorp held 80 shares of Aura Biosciences worth $535 as of Q1 2026.
  • US Bancorp sold 138 Aura Biosciences shares in Q1 2026, an estimated $792.
  • Aura Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3997 holding.
  • US Bancorp first reported a position in Aura Biosciences in Q4 2024 and has held it in 5 quarters since.
  • US Bancorp's Aura Biosciences position peaked at $1.36K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.